Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jung-Hoffmann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|January 1, 1987
Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosteroneC Jung-Hoffmann, H Kuhl
Contraception|September 1, 1989
Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptivesC Jung-Hoffmann, H Kuhl
Contraception|October 1, 1990
Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedingsC Jung-Hoffmann, H Kuhl
Clinical Obstetrics and Gynecology|December 1, 1995
Gestodene-containing contraceptivesH Kuhl, C Jung-Hoffmann, I Wiegratz
Contraception|June 1, 1995
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteinsI Wiegratz, C Jung-Hoffmann, H Kuhl
Hormone Research|January 1, 1991
Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parametersC Jung-Hoffmann, M Fitzner, H Kuhl
Hormone Research|January 1, 1995
Prodrug versus drug effects of 150 micrograms desogestrel or 3-keto-desogestrel in combination with 30 micrograms ethinylestradiol on hormonal parameters: relevance of the peak serum level of 3-keto-desogestrelH Kuhl, C Jung-Hoffmann, M Fitzner
Hormone Research|January 1, 1992
Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrelC Jung-Hoffmann, A Storch, H Kuhl
Contraception|September 1, 1988
Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrelH Kuhl, C Jung-Hoffmann, F Heidt
Contraception|December 1, 1988
Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parametersC Jung-Hoffmann, F Heidt, H Kuhl
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|January 1, 1987
Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosteroneC Jung-Hoffmann, H Kuhl
Contraception|September 1, 1989
Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptivesC Jung-Hoffmann, H Kuhl
Contraception|October 1, 1990
Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedingsC Jung-Hoffmann, H Kuhl
Clinical Obstetrics and Gynecology|December 1, 1995
Gestodene-containing contraceptivesH Kuhl, C Jung-Hoffmann, I Wiegratz
Contraception|June 1, 1995
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteinsI Wiegratz, C Jung-Hoffmann, H Kuhl
Hormone Research|January 1, 1991
Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parametersC Jung-Hoffmann, M Fitzner, H Kuhl
Hormone Research|January 1, 1995
Prodrug versus drug effects of 150 micrograms desogestrel or 3-keto-desogestrel in combination with 30 micrograms ethinylestradiol on hormonal parameters: relevance of the peak serum level of 3-keto-desogestrelH Kuhl, C Jung-Hoffmann, M Fitzner
Hormone Research|January 1, 1992
Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrelC Jung-Hoffmann, A Storch, H Kuhl
Contraception|September 1, 1988
Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrelH Kuhl, C Jung-Hoffmann, F Heidt
Contraception|December 1, 1988
Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parametersC Jung-Hoffmann, F Heidt, H Kuhl
Pageof 2